Clinical trial
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety of…
NCT00325468 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00325468 |
|---|---|
| Title | An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety of Denosumab Administration in Postmenopausal Women With Low Bone Mineral Density |
| Official title | An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety of Denosumab Administration in Postmenopausal Women With Low Bone Mineral Density |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Low Bone Mineral Density |
| Intervention type | Drug |
| Interventions | AMG 162 |
| Enrollment | 200 |
| Start date | May 1, 2006 |
| Primary completion | Mar 28, 2011 |
| Completion | Aug 2, 2012 |
| First posted | May 12, 2006 |
| Last update posted | Aug 1, 2017 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: